We have previously found evidence that tau measured on PET is related to both local and distant volume loss and diffusivity changes in PSP.59 Future studies with larger cohorts and quantitative tau burden will be needed to further investigate these relationships. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.